K930679

Substantially Equivalent

DIRECT BILIRUBIN

Applicant: Horizon Diagnostics, Inc.
Product code: CIG
Advisory panel: Clinical Chemistry
Date received: 1993-02-09
Decision date: 1993-06-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Jackson, MI, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.